Expert Opinion on Therapeutic Patents, Volume 34, Issue 1-2 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Patents, Volume 34, Issue 1-2 (2024)

See all volumes and issues
Volume 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Review

Review Article
Recent developments of HSP90 inhibitors: an updated patent review (2020-present)
Jianfeng Liu, Huangliang Shu, Qinxin Xia, Qidong You & Lei Wang
Pages: 1-15
Published online: 08 Mar 2024
AbstractforRecent developments of HSP90 inhibitors: an updated patent review (2020-present) | Full Text | References | PDF (4.4 MB) | EPUB
  • 128 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Therapeutic cysteine protease inhibitors: a patent review (2018–present)
Giulia Barchielli, Antonella Capperucci & Damiano Tanini
Pages: 17-49
Published online: 14 Mar 2024
AbstractforTherapeutic cysteine protease inhibitors: a patent review (2018–present) | Full Text | References | PDF (2.3 MB) | EPUB
  • 114 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel & Haizhen A. Zhong
Pages: 51-69
Published online: 12 Mar 2024
AbstractforTargeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023) | Full Text | References | PDF (5.2 MB) | EPUB
  • 197 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades
Md Toufiqur Rahman, Hetti Handi Chaminda Lakmal, Javeena Hussain & Chunyang Jin
Pages: 71-81
Published online: 04 Apr 2024
AbstractforTargeting the relaxin-3/RXFP3 system: a patent review for the last two decades | Full Text | References | PDF (1.2 MB) | EPUB
  • 78 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020–2023)
Barbara De Filippis, Arianna Granese & Alessandra Ammazzalorso
Pages: 83-98
Published online: 20 Mar 2024
AbstractforPeroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020–2023) | Full Text | References | PDF (1.2 MB) | EPUB
  • 110 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Anticancer drugs: where are we now?
Giuseppina De Simone et al.
Editorial | Published online: 15 May 2024
Free Access
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019-June 2023
Esther C. Y. Lee et al.
Review Article | Published online: 14 May 2024
Recent trends and challenges to overcome Pseudomonas aeruginosa infections
Alessandra Ammazzalorso et al.
Review Article | Published online: 3 May 2024
An insight into the last 5-year patents on porphyromonas gingivalis and streptococcus mutans, the pivotal pathogens in the oral cavity
Bianca Laura Bernardoni et al.
Review Article | Published online: 29 Apr 2024
View all latest articles